Slide 1: Pharmaceuticals
PHARMACEUTICALS
Slide 2: Key Data 2024
Pharmaceuticals KEY DATA 2024 Staff: 232 people 17% of the total workforce Sales: 63 M€ 10% of total sales Factories: 1 Aranjuez Export: 96% 22
Slide 3: Business Model
Pharmaceuticals BUSINESS MODEL ▪ The pharmaceuticals division produces active pharmaceutical ingredients (APIs) used in generic and brand-name medicines, with a special focus on antibiotics. ▪ These antibiotics, manufactured by the pharmaceuticals division, are recognized on the essential medicines
Slide 4: Business Model: Strengths and Challenges
Pharmaceuticals BUSINESS MODEL Strengths Challenges ▪ Mastery of the fermentation process. ▪ Incorporate new products. ▪ Production of sterile products for ▪ Open new markets. injectable use. ▪ Maintain quality standards. ▪ Strong position as a reliable, high- ▪ Face competition from emerging market
Slide 5: Biological Production Process
Pharmaceuticals BIOLOGICAL PRODUCTION PROCESS Raw materials Process units Final products Derivatives ▪ Fusidic acid Sugar Fusidic ▪ Sodium fusidate raw ▪ Diethanolamine Fermentation Extraction fusidate Oil ▪ Sterile fusidic acid Vegetable Erythromycin Salts proteins base ▪ Ethylsuccinate ▪ Stearate
Slide 6: Chemical Synthesis Production Process
Pharmaceuticals CHEMICAL SYNTHESIS PRODUCTION PROCESS Raw materials Process unit Final products Fosfomycin calcium Phosphorus trichloride Fosfomycin trometamol Probargylic alcohol Fosfomycin sodium Sterile Acid Fosfomycin fosfomycin olefinic PEA salt sodium (injectable) 6
Slide 7: Applications and Market Share
Pharmaceuticals APPLICATIONS AND MARKET SHARE Products Applications Ranking by market share Fosfomycin and salts Urinary tract infections Spain Europe World Erythromycin and salts Respiratory infections Fusidic acid - 2nd 2nd Fosfomycins 1st 2nd 3rd Azitromicina Respiratory infections Erythromycins
Slide 8: Organizational Structure and Directory
Pharmaceuticals ORGANIZATIONAL STRUCTURE AND DIRECTORY Pharmaceuticals division Sales Aranjuez factory Planning and control Division director Sales R&D Mª Carmen Cruzado Sales manager: Oscar Méndez Tel.: +34 918 090 344 Headquarters and factory E-mail: farmaciacomercial@ercros.es Quality Paseo del D
Slide 9: ESG performance
ESG performance Environmental, social and governance
Slide 10: Environment
Environment Certifications and voluntary programs ▪ ISO 14001: Reference standard for the environmental management system, implemented in all factories. ▪ ISO 14064: CO2 emissions verification standard. ▪ ISO 50001: Reference standard for the energy management system. ▪ Carbon Disclosure Project (CD
Slide 11: Safety, quality, production and distribution
Safety, quality, production and distribution Certifications ▪ ISO 45001: Standard certifying health and safety management, implemented in all factories. ▪ Sigos: Standard certifying the application of a healthy organization management system (Sigos). ▪ ISO 9001: Standard certifying quality, implemen
Slide 12: Governance and CSR
Governance and CSR Certifications and voluntary programs ▪ CSR Company: CSR Certification as a company in the Responsible Care program. ▪ IBGC: Certificate of compliance with the good corporate governance index. ▪ UNE 19601: Accreditation of the criminal compliance management system. ▪ ISO 27001: St
Slide 13: Sustainable Development Goals (SDGs)
Sustainable Development Goals (SDGs) In the development of its activity, Ercros contributes to the fulfilment of the 17 SDGs set out in the UN 2030 Agenda, although it has a special impact on: ▪ SDG 3: Good health and well-being. ▪ SDG 6: Clean water and sanitation. ▪ SDG 7: Affordable and clean ene
Slide 14: For more information
For more information: Ercros, S.A. Avenue Diagonal, 595, 5th floor 08014 Barcelona +34 934 393 009 ercros@ercros.es www.ercros.es www.linkedin.com/company/ercros/